ClinicalTrials.gg
CompletedNCT05031390Updated Aug 3, 2025

the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study

An interventional study of Physiotherapist-led training in Femoroacetabular Impingement, sponsored by Horsens Hospital. Completed at 1 site in Denmark. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-08-03.

Sponsored by Horsens Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The aim of the study is to investigate the feasibility of a training intervention in patients with femoroacetabular impingement syndrome (FAIS).

Read the detailed description

The aim of this study is to investigate the feasibility of a 12-weeks (progressive) exercise program in patients with FAIS. Feasibility is evaluated on the recruitment strategy, patient adherence to the exercises and their experiences with and motivation for performing exercises. Furthermore, the investigators wish to investigate the variation of data before and after the exercise program to help estimate a suitable sample size for a future randomized controlled trial.

02

Conditions studied

  • Femoroacetabular Impingement
03

In context

Femoracetabular Impingement

116 studies on the registry are indexed under Femoracetabular Impingement; 37 are open to participants now.

This study's enrollment of 15 is below the median of 73 across 70 interventional studies indexed under Femoracetabular Impingement.

Browse Femoracetabular Impingement studies →

Lead sponsor

Horsens Hospital is the lead sponsor of 10 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged 18-50 years old
  2. Diagnosed with FAIS according to the Warwick agreement
  3. Patients having cam morphology should have an alpha angle of > 55 degrees on an anterior-posterior radiograph.
  4. Patients having pincer should have a lateral centre edge angle of >39 degrees on an anterior-posterior radiograph.
  5. Lateral joint space width should be >3 mm.
  6. is below 30.
  7. Motivated for participation in a 12 week training program with 8 physical attendances.

Exclusion criteria

Exclusion Criteria:

  1. Received physiotherapist-led treatment in the past 3 months,
  2. Previous hip surgery in included hip or other major hip injury,
  3. Systemic conditions e.g. rheumatoid arthritis, cancer,
  4. Chronical pain syndromes,
  5. Unable to perform testing procedures,
  6. Unable to attend a 12-week treatment program or baseline and follow-up assessments
  7. to radiographs (e.g. pregnancy)
  8. Unable to read or understand questionnaires and/or instructions
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Experimental
    Physiotherapist-led training

    Physiotherapy-led training of patients with FAIS

    Procedure: Physiotherapist-led training

Interventions

  • ProcedurePhysiotherapist-led training

    Patients will undergo a 12-week physiotherapist-led training program consisting of 8 supervised sessions and home-based training in between

06

What researchers measure

Primary outcomes

  1. Number of completed exercise sessions

    Number of completed exercise sessions. A high adherence is defined as attendance of \> 75% of planned sessions

    Time frame: 0-12 weeks

  2. Completion of training program

    The training program is considered completed if patients are not dropping out of the study before the end of the 12 weeks. Completion rate will be calculated as % patients who completed the study

    Time frame: 0-12 weeks

Secondary outcomes

  1. The Copenhagen Hip and Groin Outcome Score (HAGOS)

    HAGOS is a questionnaire developed for young, active persons experiencing hip and/or groin pain. It consists of 6 subscales: Pain, Symptoms, Activities of Daily Living, Sport, Participation in Sport and Hip-related quality of life. The main subscales used in this study are HAGOS pain and sport.

    Time frame: Change from 0-12 weeks

  2. The International Hip Outcome Tool (iHOT-33)

    iHOT-33 is a questionnaire focussing at patients' hip related quality of life in 33 questions. Both a total score and sub scales: "Symptoms and functional limitations", "Sports and recreational activities", "Job related concerns" and "Social, emotional and lifestyle concerns", are extracted from the questionnaire.

    Time frame: Change from 0-12 weeks

  3. The Hip Sports Activity Scale (HSAS)

    Current physical activity measured from 0 to 8 points, 0 being no activity and 8 being an athlete

    Time frame: Change from 0-12 weeks

  4. Maximal hip muscle strength

    Change (Nm/kg) in maximal hip flexion, extension, abduction and adduction from 0-12 weeks

    Time frame: Change from 0-12 weeks

  5. One-legged hop for distance

    Change (cm) i hop distance from 0-12 weeks

    Time frame: 0-12 weeks

  6. Y-balance board

    Change (cm) in ability to perform on the y balance board from 0-12 weeks

    Time frame: 0-12 weeks

  7. Patient Acceptable Symptom State

    Patient Acceptable Symptom State (yes/no): Change in number of patients reporting yes vs. no from baseline to 12 weeks

    Time frame: 0-12 weeks

07

Study locations

1 site
  • Signe Kierkegaard
    Horsens, Danmark DK-8700, Denmark
08

References and documents

Individual participant data

Plan to share: No — Pilot study with few participants.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2021 to primary completion in Aug 2022, 11 months.

Of 42 non-industry interventional studies with no phase under Femoracetabular Impingement, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 28 and three quarters within 79. This study's 11 months is below that.

Counting every sponsor, half of 43 studies reached it within 41 months; a quarter within 28 and three quarters within 79.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2021
First posted
Sep 1, 2021
StartActual
Sep 1, 2021
Primary completionActual
Aug 1, 2022
CompletionActual
Dec 1, 2022
Last update
Aug 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05031390
Lead sponsor
Horsens Hospital
Collaborators
University of Aarhus, La Trobe University
Responsible party
Jeppe Lange (Head of Research, Horsens Hospital) — Principal investigator
First posted
Sep 1, 2021
Start date
Sep 1, 2021
Primary completion
Aug 1, 2022
Completion
Dec 1, 2022
Last update
Aug 3, 2025

Study contacts

Signe Kierkegaard, PhD
principal investigator · Regionshospitalet Horsens

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion